Literature DB >> 24792319

Complementary and alternative medicine in reducing radiation-induced skin toxicity.

Jennifer J Hu1, Tengjiao Cui, Jorge L Rodriguez-Gil, Glenn O Allen, Jie Li, Cristiane Takita, Brian E Lally.   

Abstract

Radiation therapy-induced acute and late effects, particularly skin toxicities, have significant impact on cancer patients' quality of life and long-term survival. To date, no effective topical agents have been routinely used in the clinical setting to prevent skin toxicity. Using SKH-hr1 hairless mice, we investigated two complementary and alternative medicine in their effects on inflammation and ionizing radiation (IR)-induced skin toxicity: Calendula officinalis (CO) and Ching Wan Hung (CWH). They were applied immediately following each IR dosing of 10 Gy/day for 4 days. Skin toxicity and inflammatory factors were evaluated at multiple time points up to 15 days post-radiation. Serum interleukin (IL)-1α, monocyte chemotactic protein-1 (MCP1), keratinocyte-derived chemokine (KC), and granulocyte colony-stimulating factor (G-CSF) were significantly induced by radiation. Both CO and CWH significantly inhibited IR-induced MCP1 (p < 0.01), KC (p < 0.05), and G-CSF (p < 0.001). IR-induced erythema and blood vessel dilation were significantly reduced by CWH (p < 0.001) but not by CO at day 10 post-IR. Both agents inhibited IR-induced IL-1α (p < 0.01), MCP1 (p < 0.05), and vascular endothelial growth factor (p < 0.05). There were continuous inhibitory effects of CWH on IR-induced skin toxicities and inflammation. In contrast, CO treatment resulted in skin reactions compared to IR alone. Our results suggest that both CO and CWH reduce IR-induced inflammation and CWH reduced IR-induced erythema. In summary, CWH showed promising effects in reducing IR-related inflammation and skin toxicities, and future proof-of-principal testing in humans will be critical in evaluating its potential application in preventing IR-induced skin toxicities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24792319     DOI: 10.1007/s00411-014-0540-y

Source DB:  PubMed          Journal:  Radiat Environ Biophys        ISSN: 0301-634X            Impact factor:   1.925


  23 in total

1.  Models for evaluating agents intended for the prophylaxis, mitigation and treatment of radiation injuries. Report of an NCI Workshop, December 3-4, 2003.

Authors:  Helen B Stone; John E Moulder; C Norman Coleman; K Kian Ang; Mitchell S Anscher; Mary Helen Barcellos-Hoff; William S Dynan; John R Fike; David J Grdina; Joel S Greenberger; Martin Hauer-Jensen; Richard P Hill; Richard N Kolesnick; Thomas J Macvittie; Cheryl Marks; William H McBride; Noelle Metting; Terry Pellmar; Mary Purucker; Mike E Robbins; Robert H Schiestl; Thomas M Seed; Joseph E Tomaszewski; Elizabeth L Travis; Paul E Wallner; Mary Wolpert; Daniel Zaharevitz
Journal:  Radiat Res       Date:  2004-12       Impact factor: 2.841

2.  Collapse of skin antioxidant status during the subacute period of cutaneous radiation syndrome: a case report.

Authors:  Marc Benderitter; Muriel Isoir; Valérie Buard; Valérie Durand; Christine Linard; Marie Catherine Vozenin-Brotons; Jean Steffanazi; Hervé Carsin; Patrick Gourmelon
Journal:  Radiat Res       Date:  2007-01       Impact factor: 2.841

Review 3.  Ionizing radiation: the good, the bad, and the ugly.

Authors:  Julie L Ryan
Journal:  J Invest Dermatol       Date:  2012-01-05       Impact factor: 8.551

4.  A radiation-induced gene expression signature as a tool to predict acute radiotherapy-induced adverse side effects.

Authors:  Claudia Mayer; Odilia Popanda; Burkhard Greve; Eberhard Fritz; Thomas Illig; Friederike Eckardt-Schupp; Maria Gomolka; Axel Benner; Peter Schmezer
Journal:  Cancer Lett       Date:  2011-01-13       Impact factor: 8.679

5.  Disparities in the application of adjuvant radiotherapy after breast-conserving surgery for early stage breast cancer: impact on overall survival.

Authors:  Anthony E Dragun; Bin Huang; Thomas C Tucker; William J Spanos
Journal:  Cancer       Date:  2010-12-14       Impact factor: 6.860

Review 6.  Skin toxicity during breast irradiation: pathophysiology and management.

Authors:  Jennifer L Harper; Lynette E Franklin; Joseph M Jenrette; Eric G Aguero
Journal:  South Med J       Date:  2004-10       Impact factor: 0.954

7.  Evaluation of the anti-inflammatory and analgesic properties of individual and combined extracts from Commiphora myrrha, and Boswellia carterii.

Authors:  Shulan Su; Yongqing Hua; Yanyan Wang; Wei Gu; Wei Zhou; Jin-ao Duan; Haifeng Jiang; Ting Chen; Yuping Tang
Journal:  J Ethnopharmacol       Date:  2011-12-13       Impact factor: 4.360

8.  Evaluation of the effect of topical agents on radiation-induced skin disease by reflectance spectrophotometry.

Authors:  Luisa Rizza; Antonio D'Agostino; Andrea Girlando; Carmelo Puglia
Journal:  J Pharm Pharmacol       Date:  2010-06       Impact factor: 3.765

9.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245

Review 10.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321

View more
  4 in total

1.  Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population.

Authors:  Jennifer J Hu; James J Urbanic; L Doug Case; Cristiane Takita; Jean L Wright; Doris R Brown; Carl D Langefeld; Mark O Lively; Sandra E Mitchell; Anu Thakrar; David Bryant; Kathy Baglan; Jon Strasser; Luis Baez-Diaz; Glenn J Lesser; Edward G Shaw
Journal:  J Clin Oncol       Date:  2018-07-10       Impact factor: 44.544

2.  Preclinical evaluation of collagen type I scaffolds, including gelatin-collagen microparticles and loaded with a hydroglycolic Calendula officinalis extract in a lagomorph model of full-thickness skin wound.

Authors:  D Millán; R A Jiménez; L E Nieto; I Linero; M Laverde; M R Fontanilla
Journal:  Drug Deliv Transl Res       Date:  2016-02       Impact factor: 4.617

Review 3.  A Review of the Use of Topical Calendula in the Prevention and Treatment of Radiotherapy-Induced Skin Reactions.

Authors:  Joyson Kodiyan; Kyle T Amber
Journal:  Antioxidants (Basel)       Date:  2015-04-23

Review 4.  Current Knowledge on Interactions of Plant Materials Traditionally Used in Skin Diseases in Poland and Ukraine with Human Skin Microbiota.

Authors:  Natalia Melnyk; Inna Vlasova; Weronika Skowrońska; Agnieszka Bazylko; Jakub P Piwowarski; Sebastian Granica
Journal:  Int J Mol Sci       Date:  2022-08-25       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.